Awards and recognition prizes come in different forms. In recent global competitions, two Swiss start-ups were recognised for their achievements, while three were selected to join incubation and acceleration programs to hasten product development.

The increased liquidity will be used to prepare for the launch of its first product for the treatment of insomnia and further fund Idorsia’s diversified pipeline.

Araris Biotech has obtained additional CHF 12.7 million in its seed financing round, bringing the total amount raised to CHF 15.2 million. Led by Pureos Bioventures proceeds from the round will enable Araris to advance its lead antibody-drug conjugates (ADCs) into preclinical and clinical development.

Basel-based VectivBio develops medicines for patients with serious rare diseases. Proceeds from the financing will be used to support the Phase III program of VectivBio's lead investigational product, apraglutide, to treat short bowel syndrome (SBS), early commercialization activities and further development of the pipeline through business development initiatives.

The fashion giant Zalando has acquired Zurich-based Swiss body scanning tech startup Fision to help over 34 million customers find the right size and fit for clothes online using the Fision's virtual dressing room for smartphones. The startup will remain at its headquarters in Zurich while fully integrating with Zalando.